Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Euclises
BioGenerator Accelerator Labs
4320 Forest Park Avenue, Suite 304
St. Louis, MO 63108
Phone: 314-690-1441
http://en.wikipedia.org/wiki/Euclid

Euclises Pharmaceuticals, Inc. (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company is currently headquartered within the BioGenerator Accelerator Labs at CORTEX.

Key Contact
NameTitleE-Mail
Rajesh DevrajCEORDevraj@euclises.com


Funding Events
DateAmountTypeInvestors
09/09/14$1,300,000Series A ABC Laboratories
Cultivation Capital
Helix Fund
St. Louis Arch Angels
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.